InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
100%
T+90 mean return
+50.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Krempa David, Chief Business Officer. Officer active across 1 company, notably Eton Pharmaceuticals, Inc.. In total, 14 filings have been published. Split: 0 buy · 5 sells. Total volume traded: €2.8m. History available since 12 December 2025. The latest transaction was filed on 27 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations14 total
30,591 shares@ US$3.580.011% mcap3.0% of flowCommon StockSEC:0001437749-26-018628:0
32,963 shares@ US$33.22080.11% mcap29.6% of flowCommon StockSEC:0001437749-26-018628:1
9,315 shares@ US$33.88020.031% mcap8.5% of flowCommon StockSEC:0001437749-26-018628:2
519 shares@ US$35.000.0018% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:3
25,000 shares@ US$1.380.0034% mcap0.9% of flowCommon StockSEC:0001437749-26-018628:4
12,524 shares@ US$1.370.0017% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:5
37,524 shares@ US$31.49270.12% mcap31.9% of flowCommon StockSEC:0001437749-26-018628:6
12,476 shares@ US$1.370.0017% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:7
7,203 shares@ US$3.580.0025% mcap0.7% of flowCommon StockSEC:0001437749-26-018628:8
19,679 shares@ US$31.47390.061% mcap16.7% of flowCommon StockSEC:0001437749-26-018628:9
1,942 shares@ US$15.620.0031% mcap11.2% of flowCommon StockSEC:0001437749-26-001288:0
1,942 shares@ US$15.6211.2% of flowCommon StockSEC:0001437749-26-001288
6,264 shares@ US$17.0038.8% of flowCommon StockSEC:0001437749-25-037745
6,264 shares@ US$17.000.011% mcap38.8% of flowCommon StockSEC:0001437749-25-037745:0
14 of 14 declarations
About Krempa David
David Krempa is the Chief Business Officer at Eton Pharmaceuticals, Inc. He oversees the business and development strategies of the company. His role is essential in ensuring Eton's growth and expansion.
